Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-08 Sale | 2024-04-09 6:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 26,574 | $17.87 | $474,877 | 317,600 (Direct) | View |
| 2024-03-27 Sale | 2024-03-27 7:58 pm | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 17,714 | $17.9 | $317,081 | 405,293 (Direct) | View |
| 2024-02-26 Sale | 2024-02-27 6:02 pm | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 5,577 | $24.67 | $137,585 | 112,836 (Direct) | View |
| 2024-01-08 Sale | 2024-01-09 6:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 3,732 | $29.96 | $111,811 | 96,521 (Direct) | View |
| 2023-10-06 Sale | 2023-10-06 9:59 pm | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 51,563 | $21.96 | $1,132,323 | 262,463 (Direct) | View |
| 2023-07-14 Sale | 2023-07-18 6:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 100,000 | $30.04 | $3,004,350 | 256,695 (Direct) | View |
| 2023-07-11 Sale | 2023-07-13 8:27 pm | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 71,602 | $25.04 | $1,792,899 | 36,695 (Direct) | View |
| 2023-05-01 Sale | 2023-05-02 7:02 pm | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 7,806 | $21.18 | $165,331 | 108,297 (Direct) | View |
| 2023-04-06 Sale | 2023-04-07 8:34 pm | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 8,582 | $18.16 | $155,849 | 152,478 (Direct) | View |
| 2023-02-24 Sale | 2023-02-27 9:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 3,851 | $18.78 | $72,322 | 113,619 (Direct) | View |
| 2023-01-09 Sale | 2023-01-10 8:38 pm | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 3,904 | $17.13 | $66,877 | 94,161 (Direct) | View |
| 2022-10-15 Sale | 2022-10-18 9:16 pm | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 2,804 | $15.81 | $44,331 | 79,009 (Direct) | View |
| 2022-05-02 Sale | 2022-05-03 8:58 pm | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 5,483 | $18.18 | $99,691 | 91,500 (Direct) | View |
| 2022-02-23 Sale | 2022-02-25 5:40 pm | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 3,928 | $23.8 | $93,486 | 98,570 (Direct) | View |
| 2022-01-06 Sale | 2022-01-10 6:22 pm | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 3,718 | $23.05 | $85,700 | 77,772 (Direct) | View |
| 2021-10-18 Sale | 2021-10-19 5:30 pm | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 2,963 | $17.41 | $51,586 | 58,844 (Direct) | View |
| 2021-04-30 Sale | 2021-04-30 6:52 pm | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 7,850 | $20.33 | $159,591 | 80,562 (Direct) | View |
| 2021-02-04 Sale | 2021-02-08 9:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 14,195 | $50.61 | $718,409 | 133,900 (Direct) | View |
| 2021-01-06 Sale | 2021-01-08 7:28 pm | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 3,484 | $53.34 | $185,837 | 53,065 (Direct) | View |
| 2020-10-16 Sale | 2020-10-19 5:25 pm | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 2,960 | $42.56 | $125,978 | 26,662 (Direct) | View |
| 2020-05-13 Sale | 2020-05-15 7:11 pm | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 200,000 | $46.02 | $9,204,692 | 300,351 (Direct) | View |
| 2020-04-30 Sale | 2020-05-01 6:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 6,770 | $49.21 | $333,152 | 58,684 (Direct) | View |
| 2019-12-05 Sale | 2019-12-06 6:25 pm | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 150,000 | $52.34 | $7,851,300 | 302,954 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-05 Exercise | 2024-04-09 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 51,999 | $0 | 317,600 (Direct) | View |
| 2024-03-25 Option Award | 2024-03-27 7:58 pm | N/A 2034-03-24 | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 321,117 | $0 | 405,293 (Direct) | View |
| 2024-02-23 Exercise | 2024-02-27 6:02 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 10,946 | $0 | 112,836 (Direct) | View |
| 2024-01-06 Exercise | 2024-01-09 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 9,528 | $0 | 96,521 (Direct) | View |
| 2023-10-06 Exercise | 2023-10-06 9:59 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 207,998 | $0 | 262,463 (Direct) | View |
| 2023-07-14 Exercise | 2023-07-18 6:00 pm | N/A 2024-07-14 | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 100,000 | $0 | 256,695 (Direct) | View |
| 2023-07-14 Exercise | 2023-07-18 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 100,000 | $20.77 | 256,695 (Direct) | View |
| 2023-05-01 Option Award | 2023-05-03 9:16 pm | N/A 2033-05-01 | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 385,067 | $0 | 385,067 (Direct) | View |
| 2023-04-29 Exercise | 2023-05-02 7:02 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 15,625 | $0 | 108,297 (Direct) | View |
| 2023-04-05 Exercise | 2023-04-07 8:34 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 17,333 | $0 | 152,478 (Direct) | View |
| 2023-02-23 Exercise | 2023-02-27 9:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 10,945 | $0 | 113,619 (Direct) | View |
| 2023-01-06 Exercise | 2023-01-10 8:38 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 9,528 | $0 | 94,161 (Direct) | View |
| 2023-01-03 Exercise | 2023-01-05 1:12 pm | N/A N/A | BELLICUM PHARMACEUTICALS INC | BLCM | DAVIS STEPHEN Director | 74,739 | $0 | 136,854 (Direct) | View |
| 2022-12-16 Option Award | 2022-12-20 5:19 pm | N/A 2032-12-16 | HERON THERAPEUTICS INC. | HRTX | DAVIS STEPHEN Director | 115,740 | $0 | 129,192 (Direct) | View |
| 2022-10-15 Exercise | 2022-10-18 9:16 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 5,938 | $0 | 79,009 (Direct) | View |
| 2022-09-01 Exercise | 2022-09-02 10:30 am | N/A N/A | BELLICUM PHARMACEUTICALS INC | BLCM | DAVIS STEPHEN Director | 43,400 | $0 | 62,115 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-16 2:49 pm | N/A 2032-06-14 | BELLICUM PHARMACEUTICALS INC | BLCM | DAVIS STEPHEN Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-04-29 Exercise | 2022-05-03 8:58 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 15,625 | $0 | 91,500 (Direct) | View |
| 2022-04-05 Option Award | 2022-04-07 6:39 pm | N/A 2032-04-05 | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 584,595 | $0 | 584,595 (Direct) | View |
| 2022-02-23 Exercise | 2022-02-25 5:40 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 10,945 | $0 | 98,570 (Direct) | View |
| 2022-01-06 Exercise | 2022-01-10 6:22 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 9,527 | $0 | 77,772 (Direct) | View |
| 2022-01-04 Exercise | 2022-01-06 09:31 am | N/A N/A | BELLICUM PHARMACEUTICALS INC | BLCM | DAVIS STEPHEN Director | 18,715 | $0 | 18,715 (Direct) | View |
| 2021-12-22 Option Award | 2021-12-23 6:55 pm | N/A 2031-12-22 | HERON THERAPEUTICS INC. | HRTX | DAVIS STEPHEN Director | 31,355 | $0 | 34,355 (Direct) | View |
| 2021-10-15 Exercise | 2021-10-19 5:30 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 5,938 | $0 | 58,844 (Direct) | View |
| 2021-06-15 Option Award | 2021-07-07 8:25 pm | 2022-06-15 2031-06-14 | BELLICUM PHARMACEUTICALS INC | BLCM | DAVIS STEPHEN Director | 6,500 | $0 | 6,500 (Direct) | View |
| 2021-04-29 Exercise | 2021-04-30 6:52 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 15,625 | $0 | 80,562 (Direct) | View |
| 2021-02-23 Option Award | 2021-02-25 9:45 pm | N/A 2031-02-23 | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 205,012 | $0 | 205,012 (Direct) | View |
| 2021-02-04 Option Award | 2021-02-08 9:00 pm | N/A 2027-08-03 | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 136,250 | $0 | 133,900 (Direct) | View |
| 2021-01-06 Exercise | 2021-01-08 7:28 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 9,527 | $0 | 53,065 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-05 6:35 pm | N/A N/A | BELLICUM PHARMACEUTICALS INC | BLCM | DAVIS STEPHEN Director | 18,715 | $0 | 18,715 (Direct) | View |
| 2020-12-21 Option Award | 2020-12-23 4:20 pm | N/A 2030-12-21 | HERON THERAPEUTICS INC. | HRTX | DAVIS STEPHEN Director | 21,000 | $0 | 21,000 (Direct) | View |
| 2020-10-15 Exercise | 2020-10-19 5:25 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 5,937 | $0 | 26,662 (Direct) | View |
| 2020-10-13 Option Award | 2020-10-15 4:20 pm | N/A 2030-10-13 | HERON THERAPEUTICS INC. | HRTX | DAVIS STEPHEN Director | 765 | $0 | 765 (Direct) | View |
| 2020-06-15 Option Award | 2020-06-16 4:51 pm | N/A 2030-06-14 | BELLICUM PHARMACEUTICALS INC | BLCM | DAVIS STEPHEN Director | 6,500 | $0 | 6,500 (Direct) | View |
| 2020-05-13 Exercise | 2020-05-15 7:11 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 200,000 | $19.65 | 300,351 (Direct) | View |
| 2020-05-13 Exercise | 2020-05-15 7:11 pm | N/A 2026-03-14 | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 200,000 | $0 | 300,351 (Direct) | View |
| 2020-04-29 Exercise | 2020-05-01 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 15,625 | $0 | 58,684 (Direct) | View |
| 2020-04-15 Option Award | 2020-04-17 9:07 pm | N/A 2030-04-15 | HERON THERAPEUTICS INC. | HRTX | DAVIS STEPHEN Director | 1,426 | $0 | 1,426 (Direct) | View |
| 2020-01-06 Option Award | 2020-01-08 6:04 pm | N/A 2030-01-06 | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 176,414 | $0 | 176,414 (Direct) | View |
| 2019-12-19 Option Award | 2019-12-23 4:23 pm | N/A 2029-12-19 | HERON THERAPEUTICS INC. | HRTX | DAVIS STEPHEN Director | 15,500 | $0 | 15,500 (Direct) | View |
| 2019-12-05 Exercise | 2019-12-06 6:25 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 150,000 | $19.65 | 302,954 (Direct) | View |
| 2019-12-05 Exercise | 2019-12-06 6:25 pm | N/A 2026-03-14 | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 150,000 | $0 | 302,954 (Direct) | View |